US 8247429
Tricyclic compound and pharmaceutical use thereof
granted A61PA61P15/00A61P25/20
Quick answer
US patent 8247429 (Tricyclic compound and pharmaceutical use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P15/00, A61P25/20, A61P25/28, A61P5/00